Omnicell to Release First Quarter 2017 Earnings Results on May 4, 2017
Apr 27, 2017, 16:01 ET
MOUNTAIN VIEW, Calif., April 27, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call on Thursday, May 4, 2017, to discuss the Company's first Quarter 2017 financial results.
| What: |
Omnicell First Quarter 2017 earnings conference call and webcast |
| When: |
May 4, 2017, 8:30 a.m. ET |
| Who: |
Randall Lipps, chairman, president and chief executive officer |
| Peter Kuipers, chief financial officer |
|
| Where: |
The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 36563190. The webcast can be accessed at: http://ir.omnicell.com/events.cfm. |
| How: |
Link to the Omnicell website 15 minutes prior to the call to download necessary audio software. |
| Replay: |
Available starting at 11:30 a.m. ET on May 4, 2017 through 11:59 p.m. ET on May 22, 2017. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 36563190. |
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.
OMCL-E
SOURCE Omnicell, Inc.
Share this article